Tebelay Dilnessa | Microbiology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Tebelay Dilnessa
Debre Markos University, Ethiopia

Tebelay Dilnessa
Affiliation Debre Markos University
Country Ethiopia
Google Scholar ID a5xs_XsAAAAJ
Citations 1,174
h-index 16
i10 index 22
Subject Area Microbiology
Event International Molecular Biologist Awards
ORCID 0000-0002-3713-6783
Scopus 57190571702

Tebelay Dilnessa is a microbiology researcher affiliated with Debre Markos University in Ethiopia. His documented research activity encompasses medical microbiology, infectious diseases, antimicrobial resistance, tuberculosis, bacterial infections, diagnostic microbiology, and related public-health questions. His scholarly record includes collaborative research addressing clinically relevant microorganisms and laboratory-based investigation of infectious diseases. [1] [5]

Abstract

Tebelay Dilnessa is a microbiology researcher whose scholarly work is associated with medical laboratory science, infectious diseases, antimicrobial resistance, tuberculosis, bacterial pathogens, and diagnostic microbiology. His publication record includes studies of antimicrobial susceptibility, infectious disease epidemiology, laboratory diagnosis, and systematic evidence synthesis. Available scholarly records identify Debre Markos University among his institutional affiliations and document his contribution to collaborative research in microbiology and related biomedical disciplines. [1] [4]

Keywords

Microbiology; medical microbiology; antimicrobial resistance; infectious diseases; tuberculosis; bacterial pathogens; antimicrobial susceptibility; diagnostic microbiology; public health; molecular microbiology.

Introduction

Microbiology integrates the study of microorganisms with laboratory methods used to understand infectious diseases, antimicrobial susceptibility, pathogen transmission, and diagnostic challenges. Within this broad field, research on bacterial resistance and infectious disease surveillance has particular relevance to clinical laboratory practice and public health.

Dilnessa’s published work reflects this applied microbiological orientation. His research has included investigations of bacterial pathogens, antimicrobial resistance patterns, tuberculosis, viral infection diagnosis, intestinal parasites, and other infectious disease questions. A number of these studies were conducted in collaboration with researchers and clinical institutions in Ethiopia, providing evidence from local healthcare settings. [2] [3]

Research Profile

Dilnessa’s research profile is centered on microbiology and medical laboratory science, with recurring themes involving infectious agents, antimicrobial susceptibility, epidemiology, and laboratory-based characterization of pathogens. His work spans both primary research and evidence synthesis, allowing his publication record to address individual clinical settings as well as broader patterns reported across multiple studies.

  • Medical and clinical microbiology, including investigation of bacterial pathogens and laboratory findings.
  • Antimicrobial resistance and susceptibility testing, particularly involving clinically important bacterial species.
  • Tuberculosis and other infectious diseases affecting public health in Ethiopia.

The combination of these areas places his work within an applied research framework connecting microbiological investigation with clinical laboratory practice and public-health research. [1] [5]

Research Contributions

One notable area of Dilnessa’s research concerns antimicrobial resistance. His publications have examined antimicrobial susceptibility patterns and resistance among bacterial isolates, contributing data relevant to the interpretation of resistance in clinical and healthcare environments. Such studies are important because laboratory susceptibility information can support epidemiological understanding and inform approaches to antimicrobial stewardship.

His work also includes research on tuberculosis and associated infections. Research involving tuberculosis patients and co-infections contributes to the broader evidence base concerning disease burden, risk factors, treatment challenges, and laboratory surveillance in resource-constrained healthcare settings. [4]

Dilnessa has additionally contributed to research concerning diagnostic approaches to viral infections, intestinal parasites, ocular infections, and other microbiological conditions. These studies demonstrate the breadth of his work across laboratory diagnosis, pathogen identification, epidemiology, and antimicrobial susceptibility testing. [2] [3]

Publications

Dilnessa’s publication record includes collaborative articles appearing in journals covering infectious diseases, microbiology, antimicrobial resistance, and public health. Examples of documented publications include the following:

  • “Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis,” published in PLoS ONE in 2022. [4]
  • “Evaluation of wet mount and concentration techniques of stool examination for intestinal parasites identification at Debre Markos Comprehensive Specialized Hospital, Ethiopia,” published in Infection and Drug Resistance in 2021. [2]
  • “Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia,” published in Frontiers in Microbiology in 2025. [5]

Research Impact

According to the academic metrics supplied for this recognition profile, Dilnessa has accumulated 1,174 citations, an h-index of 16, and an i10-index of 22. These indicators provide quantitative measures of the visibility and citation activity associated with his scholarly publications. Citation metrics can vary between databases and over time; therefore, the figures should be interpreted in relation to the relevant indexing platform and the date on which the profile was assessed. [1] [5]

Beyond numerical indicators, the subject areas represented in his publications demonstrate sustained engagement with infectious disease and microbiological research. Studies addressing antimicrobial resistance, tuberculosis, bacterial infections, and laboratory diagnosis have practical relevance to healthcare systems and public-health surveillance, particularly in settings where locally generated microbiological evidence is important.

Award Suitability

The research profile of Tebelay Dilnessa is aligned with the scientific scope of an Innovative Molecular Biologist Award through its emphasis on microbiology, infectious disease research, antimicrobial resistance, pathogen investigation, and laboratory science. His body of work demonstrates sustained participation in collaborative research addressing microbiological problems with clinical and public-health relevance.

The documented combination of primary research, systematic evidence synthesis, laboratory investigation, and publication activity provides a scholarly basis for recognition within a microbiology-focused molecular biology awards framework. The award designation presented on this page is associated with the International Molecular Biologist Awards and should be understood as an academic recognition profile rather than an independent bibliometric ranking. [2] [4]

Conclusion

Tebelay Dilnessa is a microbiology researcher affiliated with Debre Markos University whose scholarly work encompasses antimicrobial resistance, infectious diseases, tuberculosis, bacterial pathogens, diagnostic microbiology, and evidence synthesis. His publications contribute to the scientific literature through laboratory-based investigations and collaborative studies addressing clinically and epidemiologically important microbiological questions.

Based on the supplied academic profile and documented publication activity, his research represents a sustained contribution to microbiology and related biomedical research areas. His ORCID, Scopus, and Google Scholar profiles provide additional routes for examining his scholarly record and current research output.

References

  1. Elsevier. (n.d.). Scopus author details: Tebelay Dilnessa, Author ID 57190571702. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57190571702
  2. Dove Medical Press. (n.d.). Tebelay Dilnessa — Author Profile and Published Papers. Dove Medical Press.
    https://www.dovepress.com/author-profile/966185
  3. ORCID. (n.d.). Tebelay Dilnessa — ORCID record. ORCID.
    https://orcid.org/0000-0002-3713-6783
  4. Dilnessa, T., Getaneh, A., Hailu, W., Moges, F., & Gelaw, B. (2022). Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis.
    https://doi.org/10.1371/journal.pone.0262597
  5. Addis, Z., Aschale, Y., Fenta, A., Teffera, Z. H., Melkamu, A., Tigab, A., & Dilnessa, T. (2025). Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia. Frontiers in Microbiology,.
    https://doi.org/10.3389/fmicb.2025.1569242

Mohammad Asadzadeh | Microbiology | Excellence in Research Award

Published on by Molecular Biologist

Dr. Mohammad Asadzadeh | Microbiology | Excellence in Research Award

Teaching Assistant | Kuwait University | Kuwait

Dr. Mohammad Asadullah Asadzadeh is an Iranian clinical microbiologist and academic based in Kuwait, specializing in medical and molecular mycology. His work bridges teaching, diagnostic laboratory practice, and research, with emphasis on Candida epidemiology, antifungal resistance, and molecular characterization of fungal pathogens relevant to the Middle East. He has contributed extensively to hospital and national reference laboratories, supporting public health microbiology and evidence-based diagnostics. His scholarly impact includes 50 scientific documents, 1,116 citations across 780 citing publications, and an h-index of 20, reflecting sustained contributions to clinical microbiology and translational fungal research.

Citation Metrics (Scopus)

1200

1000

800

600

400

200

0

Citations
1,116

Documents
50

h-index
20

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile View ORCID Author Profile

Featured Publications

Alaa Niamah | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Alaa Niamah | Microbiology | Best Researcher Award 

Professor of Microbiology | University of Basrah | Iraq

Prof. Dr. Alaa Kareem Niamah is a Professor of Dairy Microbiology at the University of Basrah, Iraq, recognized for his extensive research in food microbiology, probiotics, bacteriocins, and dairy biotechnology. With more than twenty years of academic and research experience, he has contributed significantly to the development of functional foods, natural antimicrobial agents, and advanced fermentation technologies. His scientific impact is reflected in 1,038 citations across 929 documents, supported by 47 published documents and an h-index of 17. Dr. Niamah’s work addresses microbial interactions, food safety, enzymatic activity, and the optimization of dairy and plant-based fermentation systems. He has collaborated with international institutions, supervised postgraduate research, and served on editorial boards, scientific committees, and conference panels in multiple countries. Through his interdisciplinary approach to microbial biotechnology and dairy science, he continues to advance innovative solutions for food quality, safety, and sustainable production.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Management of agri-food wastes via novel biotechnological methods: Emerging trends and technological advances. In Editor1, E. E. (Ed.)

 Applications of green synthesis of nanoparticles using microorganisms in food and dairy products: A review. Journal Name, Volume(Issue)

Immunomodulation capability and cytotoxicity activities of novel exopolysaccharides produced by a new local strain, Bifidobacterium longum subsp. infantis strain Iraq-Basrah 3. Journal of Applied Biology and Biotechnology, Volume(Issue),

Exploring the chemistry and sources of microbial 1,2-propanediol (propylene glycol) with a focus on biosynthesis, extraction, and identification for nutraceutical significance and human health. In Editor1, E. E. (Ed.)

Rekha Thiruvengadam | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Rekha Thiruvengadam | Microbiology | Best Researcher Award

Professor, at Saveetha medical college and hospital, India.

Dr. K. Rekha is a distinguished microbiologist and Professor at Helix Research Lab, Department of Community Medicine, Saveetha Institute of Medical and Technical Sciences, Tamil Nadu, India. With over two decades of academic and research experience, she specializes in virology, antimicrobial resistance, nanotechnology, and environmental microbiology. Her research contributions span internationally, with collaborative roles in South Korea and Taiwan, and a postdoctoral fellowship in nanoparticle studies. She has mentored Ph.D. scholars, published in high-impact journals, and presented at numerous national and international symposia. Dr. Rekha has received awards for academic excellence and is recognized for her innovative research in biosciences, including patent achievements and esteemed journal reviews. Driven by a commitment to scientific advancement and academic mentorship, she continues to make impactful contributions to global health through microbial innovation and natural product pharmacology. 🌱🔬

Professional Profile

Scopus

Google scholar

🎓 Education 

Dr. Rekha holds a Ph.D. in Microbiology (2011–2016) from Tamil University, where she explored antiviral potentials of medicinal plant extracts and synthesized silver nanoparticles for infectious bursal disease virus (IBDV) treatment. Her M.Phil. in Biotechnology (2003–2004) and M.Sc. in Microbiology (1999–2001) were both completed at Bharathidasan University, India, where she laid the foundation for her scientific research career. She began her academic journey with a B.Sc. in Microbiology (1997–1999) from the same institution. Her educational path is defined by interdisciplinary exposure across microbiology, environmental sciences, and biotechnology. Her doctoral work included extensive analysis of phenolic compounds and nanoparticle-mediated viral inhibition. Her academic mentors include Dr. C. Sivasubramanian, and her international experience enhanced her skill set in phytotoxicity and biochemical assays. Her diverse academic background laid the groundwork for a research career that bridges traditional knowledge and modern biomedical innovation. 📚🧪

🧪 Experience 

Dr. K. Rekha brings over 20 years of rich academic and research experience, with roles across India, South Korea, and Taiwan. She currently serves as Professor at Helix Research Lab, Saveetha Institute, where she mentors scholars and leads research on infectious diseases. From 2022 to 2024, she was a Research Professor at Sejong University, South Korea, working on the links between hypertension and cancer. Previously, she served as an Assistant Professor at MIET College, India (2018–2022), and as a Postdoctoral Fellow at Konkuk University, South Korea (2016–2017), focusing on plant-microbe interactions. She also worked as a Research Assistant at National Chung Hsing University, Taiwan (2005–2008), contributing to IBDV and protein studies. Starting her academic career as a Lecturer at St. Joseph’s College (2001–2005), Dr. Rekha has also taught undergraduate and postgraduate students in microbiology and biotechnology. Her international exposure shaped her innovative and global approach to research. 🌍📖

🔬 Research Interest 

Dr. K. Rekha’s research centers on microbiology, nanotechnology, plant-derived antiviral compounds, and environmental biotechnology. Her doctoral research investigated the biosynthesis and antimicrobial activity of silver nanoparticles from Momordica charantia, demonstrating efficacy against IBDV. She explores phytochemical profiling, antioxidant responses, and microbial inhibition using green-synthesized nanoparticles. In recent years, she extended her research to examine correlations between hypertension and cancer, and she uses computational biology to identify therapeutic targets for metabolic disorders. Her interests include epidemiology, enzyme inhibition, and biosafety of nanoparticles. She also engages in biotechnological applications of algae for biofuel production and has published on anti-inflammatory properties of medicinal extracts. As a passionate advocate for nature-based therapies and sustainable biotechnology, she works at the intersection of traditional herbal sciences and modern nanomedicine. 🧬🌿⚗️

🏆 Awards 

Dr. K. Rekha has earned recognition both nationally and internationally for her academic excellence and research innovation. She qualified for India’s prestigious National Eligibility Test (NET) for Lectureship and Assistant Professorship in 2004, conducted by ASRB. In 2023, she received the Excellent Poster Presentation Award from the Korean Society of Environmental Health and Toxicology for her innovative work on optimizing algae conditions for biodiesel production. Her patent, titled “A method for preventing microbial contamination of fresh fruits and vegetables”, granted in 2023, reflects her translational research impact. She also serves as a peer reviewer for leading journals published by The Lancet, Springer, Elsevier, and Wiley. Her consistent contributions to microbial science and natural product biotechnology have earned her a place among globally respected scientists. 🏅🔖📄

📚 Top Noted Publications

Dr. Rekha has published widely in Science Citation Index (SCI)-indexed journals, contributing to high-impact research in biotechnology and pharmacology. Her recent publications include:

1. Drug Repurposing for Lassa Virus

  • Journal: Journal of Computational Biophysics and Chemistry

  • Publication Year: 2025

  • Details: I couldn’t locate specific information about this paper. You might consider checking the journal’s official website or academic databases for more details.

2. Biomarkers in Lung Cancer Treatment

  • Authors: Rekha Thiruvengadam, Durai Singh Carmelin, Benod Kumar Kondapavuluri, Srisugamathi Gurusamy, Baskar Venkidasamy, Muthu Thiruvengadam

  • Journal: Clinica Chimica Acta

  • Publication Date: March 28, 2025

  • DOI: 10.1016/j.cca.2025.120267

  • Summary: This paper discusses the role of biomarkers in the treatment of lung cancer, focusing on their potential to enhance diagnostic accuracy and therapeutic strategies.CoLab

3. Antidiabetic Algae Peptides Study

  • Journal: International Journal of Biological Macromolecules

  • Publication Year: 2025

  • Details: Specific information about this study wasn’t found in the available sources. For more details, please refer to the journal’s publications or relevant scientific databases.

4. PGP Actinomycetes Consortia Study

  • Journal: Journal of Microbiology and Biotechnology

  • Publication Year: 2025

  • Details: I couldn’t find specific details about this study. You may want to consult the journal’s archives or academic search engines for more information.

5. Bioactive Nanoparticles for Oxidative Stress

  • Journal: Industrial Crops and Products

  • Publication Year: 2025

  • Details: No specific information was located regarding this paper. Checking the journal’s official publications or scientific repositories might provide the needed details.CoLab+1MDPI+1

6. Pomegranate in Cancer Prevention

  • Journal: Food Science & Nutrition

  • Publication Year: 2025

  • Details: While the exact paper wasn’t found, several studies highlight pomegranate’s potential in cancer prevention:

    • Pomegranate extracts exhibit anti-inflammatory and antioxidant properties, modulating signaling pathways involved in cancer progression.

    • Compounds like punicalagin and ellagic acid in pomegranate have shown anticancer activities in various studies. PubMed+1PubMed+1MDPI+4Bentham Science+4SpringerLink+4

Conclusion

Dr. K. Rekha is a highly accomplished and dedicated researcher with a diverse academic portfolio, consistent international research contributions, and a strong record of mentorship and publications. Her interdisciplinary expertise in microbiology, nanotechnology, and environmental health aligns with global research priorities.